ERBB2 and breast cancer: Interestingly, in breast cancer cells exhibiting a strong promoting role of CD151, receptor tyrosine kinases (RTKs) (e.g., EGFR, ErbB2, c-Met and Ron) or K-Ras are frequently activated because of gene amplification/overexpression or mutations (Figure 1) [1].